Biomarkers for high-risk influenza patients: what are the next steps?

Tang, Benjamin M; Shojaei, Maryam; Branley, James; McLean, Anthony

Tang, Benjamin M; Shojaei, Maryam; Branley, James; McLean, Anthony.

Afiliación

Tang BM; a Department of intensive care medicine , Nepean Hospital , Sydney , Australia.
Shojaei M; b Centre for immunology and allergy research , the Westmead institute for medical research , Sydney , Australia.
Branley J; c Respiratory virus infection research , Marie Bashir institute for infectious diseases and biosecurity , Sydney , Australia.
McLean A; a Department of intensive care medicine , Nepean Hospital , Sydney , Australia.

Expert Rev Mol Diagn ; 18(3): 205-206, 2018 03.

Article en En | MEDLINE | ID: mdl-29264948

Asunto(s)

Gripe Humana/sangre; Pandemias; Biomarcadores/sangre; Susceptibilidad a Enfermedades/sangre; Susceptibilidad a Enfermedades/epidemiología; Humanos; Gripe Humana/epidemiología

Palabras clave

Influenza; biomarkers; host response; risk stratification

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Gripe Humana / Pandemias Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Rev Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google